Skip to main content

Hajduová Katarína

Journals

Paving the way for future PSMA inhibitors: insights from comparative preclinical evaluations of structure modifications. EJNMMI Radiopharmacy and Chemistry. 2025, 10(1), 63, ISSN: 2365-421X, PMID: 41003962,
TROMMER, J., M. ULLRICH, F. REISSIG, S. BRUHLMANN, A. NITT-WEBER, Z. NOVÝ, K. HAJDUOVÁ, D. KURFÜRSTOVÁ, R. HENDRYCHOVÁ, J. BOUCHAL, M. PETŘÍK, C. NEUBER, W. SIHVER, S. STADLBAUER, H. PIETZSCH, M. KRELLER, K. KOPKA, C. MAMAT, K. ZACHSLER
It's a match: use of the radionuclide theranostic pair 133La/225Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies. EJNMMI Radiopharmacy and Chemistry. 2025, 10(1), 31, ISSN: 2365-421X, PMID: 40536585,
ONDRÁK FIALOVÁ, K., K. ONDRAK , M. VLK, J. KOZEMPEL, K. NOVÁKOVÁ, Z. NOVÝ, K. HAJDUOVÁ, M. HAJDÚCH, M. PETŘÍK, M. PRUSZYNSKI, F. BRUCHERTSEIFER, A. MORGENSTERN
In vitro and in vivo evaluation of anti-HER2 antibody conjugates labelled with 225Ac. EJNMMI Radiopharmacy and Chemistry. 2025, 107(1), 16, ISSN: 2365-421X, PMID: 40183827,